Your session is about to expire
← Back to Search
Progesterone for Transgender Individuals
Study Summary
This trial is testing whether or not progesterone affects testosterone levels in transwomen who are already taking estradiol as part of their gender affirming treatment. Participation will last for six months, during which time participants will have to give blood and take a pill once daily. There are no known risks for taking progesterone, but it may have benefits like increasing fat mass and breast size, and decreasing masculine hair patterns.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Who is running the clinical trial?
Media Library
- You have a history of gallbladder disease, except if your gallbladder has been removed through surgery.You have taken progesterone within the past 2 months.You are planning to have breast augmentation or gender reassignment surgery within the next 6 months.You are a transgender woman who has been taking estradiol for at least 6 months as part of your gender-affirming therapy.
- Group 1: progesterone
- Group 2: placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are taking part in this research initiative?
"Affirmative. The information hosted on clinicaltrials.gov suggests that this medical research study is actively recruiting its participants, with the first posting taking place on October 20th 2020 and last amendment occurring June 30th 2022. This trial requires enrolment of twenty individuals at a solitary site."
Is this research project enlisting individuals aged seventy or above?
"This medical trial is only open to individuals aged between 18 and 65. On the other hand, 8 separate trials offer aid for minors while there are 14 studies specifically tailored to elderly patients."
Are there any remaining spots for participation in this experimental trial?
"Clinicaltrials.gov attests that this experiment is actively enrolling participants, with the initial advertisement being posted on October 20th 2020 and the most recent update taking place June 30 2022."
How is progesterone generally utilized to benefit patient health?
"Utilizing progesterone, medical professionals may be able to treat uterine hemorrhage, rectify hormonal imbalances, and reduce the risk of spontaneous preterm birth recurrence."
To what extent can progesterone be detrimental to individuals?
"Our experts at Power have evaluated progesterone to be moderately safe, giving it a rating of 2. This is because clinical trials are only in Phase 2 and there exists some evidence for safety but none suggesting efficacy."
For which demographic is this clinical trial most suitable?
"Individuals between 18 and 65 who identify as transgender are eligible for this trial. A maximum of 20 people may participate in the study."
Have there been precedent studies that have investigated the efficacy of progesterone?
"Currently, there are 42 clinical trials exploring the use of progesterone with 8 studies in its final phase. Barcelona, Catalunya is home to a few of these experiments though overall there are 268 sites hosting progesterone research."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Saint Louis University: < 48 hours
Average response time
- < 2 Days
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger